Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
The introduction of new and more effective therapeutic options for Multiple Myeloma (MM) has significantly deepened and prolonged patients’ remission. As currently used treatment protocols induce high rates of complete responses, Measurable Residual Disease (MRD) assessment has become essential to e...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2022-06-01
|
| Edice: | Hemato |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2673-6357/3/3/27 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|